← Eichor
Study identifier: NCT05649007 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery

Condition: Arthropathy of Hip  ·  Sponsor: Gruppo Bioimpianti S.r.l.

PhaseN/A
Planned participants630
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Post-market clinical follow up investigation on the use of saphir stem and FIN Cup or Dualis system in the treatment of pathologies requiring hip arthroplasty. The main object of the clinical investigation is the evaluation of long term survival rate of Saphir stem.

This description comes directly from the study's public registry record.

Talk to the study team

Alessio Vitale, Biotech  ·  +390251650371  ·  regulatory@bioimpianti.it

Fabio Stringhi, biomedic eng  ·  patients under guardianship or  ·  fabio.stringhi@bioimpianti.it

Always discuss trial participation with your own doctor first.

Locations (1)

Hopital DucuingToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05649007